(Q33525137)

27 July 2017

title

Virtual screening and drug design for PDE-5 receptor from traditional Chinese medicine database (English)

1 reference

traditional Chinese medicine

27 July 2017

0 references

0 references

1 reference

1 reference

based on heuristic

inferred from title

object named as

traditional Chinese medicine

17 February 2024

author name string

Calvin Yu-Chian Chen

series ordinal

1

1 reference

27 July 2017

publication date

1 April 2010

1 reference

Journal of Biomolecular Structure and Dynamics

27 July 2017

published in

1 reference

27 July 2017

volume

27

1 reference

27 July 2017

issue

5

1 reference

27 July 2017

page(s)

627-640

1 reference

Cyclic nucleotide phosphodiesterases: relating structure and function

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Noncholinergic penile erection in mice lacking the gene for endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Erectile dysfunction and its influence on quality of life in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Synthesis and phosphodiesterase 5 inhibitory activity of novel pyrido[1,2-e]purin-4(3H)-one derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

A clinical study on global TCM therapy in treating senile advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Discovery of potent inhibitors for phosphodiesterase 5 by virtual screening and pharmacophore analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Construction and assessment of reaction models of class I EPSP synthase: molecular docking and density functional theoretical calculations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

A docking study using atomistic conformers generated via elastic network model for cyclosporin A/cyclophilin A complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Homology modeling of GLUT4, an insulin regulated facilitated glucose transporter and docking studies with ATP and its inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Homology modeling of wild-type, D516V, and H526L Mycobacterium tuberculosis RNA polymerase and their molecular docking study with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Molecular dynamics, flexible docking, virtual screening, ADMET predictions, and molecular interaction field studies to design novel potential MAO-B inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Molecular dynamics simulations to investigate the aggregation behaviors of the Abeta(17-42) oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Studies on the structural stability of rabbit prion probed by molecular dynamics simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Weighted equation and rules--a novel concept for evaluating protein-ligand interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Computational screening and design of traditional Chinese medicine (TCM) to block phosphodiesterase-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Ligand-based dual target drug design for H1N1: swine flu--a preliminary first study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

What is the effective component in suanzaoren decoction for curing insomnia? Discovery by virtual screening and molecular dynamic simulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Understanding the structure-activity and structure-selectivity correlation of cyclic guanine derivatives as phosphodiesterase-5 inhibitors by molecular docking, CoMFA and CoMSIA analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Investigation of aminopyridiopyrazinones as PDE5 inhibitors: Evaluation of modifications to the central ring system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Identification, synthesis and SAR of amino substituted pyrido[3,2b]pyrazinones as potent and selective PDE5 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

3D-QSAR studies on sildenafil analogues, selective phosphodiesterase 5 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

The Discovery of Tadalafil: A Novel and Highly Selective PDE5 Inhibitor. 1: 5,6,11,11a-Tetrahydro-1H-imidazo[1‘,5‘:1,6]pyrido[3,4-b]indole-1,3(2H)-dione Analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

The Discovery of Tadalafil: A Novel and Highly Selective PDE5 Inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1‘,2‘:1,6]pyrido[3,4-b]indole-1,4-dione Analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

2-Phenylquinazolin-4(3H)-one, a class of potent PDE5 inhibitors with high selectivity versus PDE6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

A general and fast scoring function for protein-ligand interactions: a simplified potential approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07391102.2010.10508577

10.1080/07391102.2010.10508577

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference